Librería: Universitätsbuchhandlung Herta Hold GmbH, Berlin, Alemania
EUR 18,00
Cantidad disponible: 2 disponibles
Añadir al carritoIX, 238 p. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Current Cancer Research. Sprache: Englisch.
Librería: Buchpark, Trebbin, Alemania
EUR 15,76
Cantidad disponible: 2 disponibles
Añadir al carritoCondición: Hervorragend. Zustand: Hervorragend | Sprache: Englisch | Produktart: Bücher | This book contextualizes translational research and provides an up to date progress report on therapies that are currently being targeted in lung cancer. It is now well established that there is tremendous heterogeneity among cancer cells both at the inter- and intra-tumoral level. Further, a growing body of work highlights the importance of targeted therapies and personalized medicine in treating cancer patients. In contrast to conventional therapies that are typically administered to the average patient regardless of the patient¿s genotype, targeted therapies are tailored to patients with specific traits. Nonetheless, such genetic changes can be disease-specific and/or target specific; thus, the book addresses these issues manifested in the somatically acquired genetic changes of the targeted gene. Each chapter is written by a leading medical oncologist who specializes in thoracic oncology and is devoted to a particular target in a specific indication. Contributors provide an in-depth review of the literature covering the mechanisms underlying signaling, potential cross talk between the target and downstream signaling, and potential emergence of drug resistance.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 139,90
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 153,95
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 139,89
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 156,42
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 155,08
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Librería: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
EUR 163,53
Cantidad disponible: 15 disponibles
Añadir al carritoCondición: New.
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 181,71
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. pp. 238.
Idioma: Inglés
Publicado por Springer International Publishing, Springer International Publishing, 2019
ISBN 10: 3030178315 ISBN 13: 9783030178314
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 139,09
Cantidad disponible: 1 disponibles
Añadir al carritoBuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book contextualizes translational research and provides an up to date progress report on therapies that are currently being targeted in lung cancer. It is now well established that there is tremendous heterogeneity among cancer cells both at the inter- and intra-tumoral level. Further, a growing body of work highlights the importance of targeted therapies and personalized medicine in treating cancer patients. In contrast to conventional therapies that are typically administered to the average patient regardless of the patient's genotype, targeted therapies are tailored to patients with specific traits. Nonetheless, such genetic changes can be disease-specific and/or target specific; thus, the book addresses these issues manifested in the somatically acquired genetic changes of the targeted gene. Each chapter is written by a leading medical oncologist who specializes in thoracic oncology and is devoted to a particular target in a specific indication. Contributors provide an in-depth review of the literature covering the mechanisms underlying signaling, potential cross talk between the target and downstream signaling, and potential emergence of drug resistance.
Librería: Revaluation Books, Exeter, Reino Unido
EUR 193,85
Cantidad disponible: 2 disponibles
Añadir al carritoHardcover. Condición: Brand New. 248 pages. 9.25x6.10x0.71 inches. In Stock.
Librería: Kennys Bookstore, Olney, MD, Estados Unidos de America
EUR 204,02
Cantidad disponible: 15 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por Springer International Publishing Jul 2019, 2019
ISBN 10: 3030178315 ISBN 13: 9783030178314
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
EUR 69,54
Cantidad disponible: 2 disponibles
Añadir al carritoBuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book contextualizes translational research and provides an up to date progress report on therapies that are currently being targeted in lung cancer. It is now well established that there is tremendous heterogeneity among cancer cells both at the inter- and intra-tumoral level. Further, a growing body of work highlights the importance of targeted therapies and personalized medicine in treating cancer patients. In contrast to conventional therapies that are typically administered to the average patient regardless of the patient's genotype, targeted therapies are tailored to patients with specific traits. Nonetheless, such genetic changes can be disease-specific and/or target specific; thus, the book addresses these issues manifested in the somatically acquired genetic changes of the targeted gene. Each chapter is written by a leading medical oncologist who specializes in thoracic oncology and is devoted to a particular target in a specific indication. Contributors provide an in-depth review of the literature covering the mechanisms underlying signaling, potential cross talk between the target and downstream signaling, and potential emergence of drug resistance. 248 pp. Englisch.
Librería: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 110,26
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: new. Questo è un articolo print on demand.
Idioma: Inglés
Publicado por Springer International Publishing, 2019
ISBN 10: 3030178315 ISBN 13: 9783030178314
Librería: moluna, Greven, Alemania
EUR 118,61
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Focus on lung cancer and findings from multiple clinical centers. Emphasis on RTKs, the most desirable candidates for targeted therapy.  Contextualizes translational research, including a discussion of the .
Librería: Majestic Books, Hounslow, Reino Unido
EUR 191,74
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. Print on Demand pp. 238.
Idioma: Inglés
Publicado por Springer, Springer Jul 2019, 2019
ISBN 10: 3030178315 ISBN 13: 9783030178314
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania
EUR 139,09
Cantidad disponible: 1 disponibles
Añadir al carritoBuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -This book contextualizes translational research and provides an up to date progress report on therapies that are currently being targeted in lung cancer. It is now well established that there is tremendous heterogeneity among cancer cells both at the inter- and intra-tumoral level. Further, a growing body of work highlights the importance of targeted therapies and personalized medicine in treating cancer patients. In contrast to conventional therapies that are typically administered to the average patient regardless of the patient¿s genotype, targeted therapies are tailored to patients with specific traits. Nonetheless, such genetic changes can be disease-specific and/or target specific; thus, the book addresses these issues manifested in the somatically acquired genetic changes of the targeted gene. Each chapter is written by a leading medical oncologist who specializes in thoracic oncology and is devoted to a particular target in a specific indication. Contributors provide an in-depth review of the literature covering the mechanisms underlying signaling, potential cross talk between the target and downstream signaling, and potential emergence of drug resistance.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 248 pp. Englisch.
Librería: Biblios, Frankfurt am main, HESSE, Alemania
EUR 190,95
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. PRINT ON DEMAND pp. 238.